1-248145745-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004690.1(OR2M5):c.598T>A(p.Phe200Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,760 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004690.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2M5 | NM_001004690.1 | c.598T>A | p.Phe200Ile | missense_variant | 1/1 | ENST00000366476.1 | NP_001004690.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2M5 | ENST00000366476.1 | c.598T>A | p.Phe200Ile | missense_variant | 1/1 | 6 | NM_001004690.1 | ENSP00000355432.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251124Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135714
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461568Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727100
GnomAD4 genome AF: 0.000118 AC: 18AN: 152192Hom.: 1 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.598T>A (p.F200I) alteration is located in exon 1 (coding exon 1) of the OR2M5 gene. This alteration results from a T to A substitution at nucleotide position 598, causing the phenylalanine (F) at amino acid position 200 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at